News About: Pharm. Industry
Bayer Healthcare to gear up for Primovist, Nexavar comarketing
Bayer Healthcare has strengthened its presence in the domestic liver market by copromoting its magnetic resonance imaging (MRI) contrast agent Primovist (gadoxetate disodium) for the detection and characterization of ...
Government to push cut in drug prices
The government will implement controversial drug pricing and reimbursement policies sooner or later despite opposition from pharmaceutical companies, according to market analysts.
The Health and Welfare Ministry hi...
Samyang Genex to gear up for supply of docetaxel to generic drugmakers
Samyang Geex has unveiled its plan to manufacture the first industrial-scale current good manufacturing practice (cGMP) batch of its key intermediate for docetaxel, the active pharmaceutical ingredient (API) of Sanofi...
Swine flu boosts sales of hand sensitizers
Influenza A fears are becoming an increasing boon for companies making hand sensitizers - so much so that they're having trouble keeping up with demand. Using a liquid or gel hand sensitizer is common and an everyday ...
Pharmaceutical firms developing lipid-lowering medicines
Korean pharmaceutical firms are preparing to challenge AstraZeneca’s grip on the lipid-lowering medicine market with generics of rosuvastatin, according to the Korea Food and Drug Administration.
According to the ...
Boryung to bid for flu vaccine program
Korea's Boryung Pharmaceutical Co. says it will bid to supply flu vaccines to the Korean goverment as it looks to inoculate millions in Korea
“Time is pressing because we will be able to provide vaccines by Novembe...
Otsuka Pharmaceutical to invest 100 billion won in Korea
Otsuka Pharmaceutical Co., one of Japan's leading drug companies, will invest around 100 billion won in Korea on research and development activities over the next five years.
The company president Iwamoto and Korea...
Chong Kun Dang pins hopes on new antidiabetic agent
With local pharmaceutical companies competing within and beyond national borders, Chong Kun Dang Pharmaceuticals may find that its latest breakthrough will give it a leg up in the market.
The Korea Food and Drug A...
Choong-wae launches treatment for dysuria associated with benign prostatic hyperplasia
Choong-wae Pharm said it has recently launched Thrupas (silodosin), a new α1-adrenoceptor antagonist with high uroselectivity
By selectively blocking alpha 1A-adrenoceptors that primarily exist in the prostate glan...
Ominous sign for Korean drugmakers
Along with the government’s strong will to cut the prices of drugs in question by 20 percent if their producers are found to offer rebates to doctors and pharmacists, domestic companies have again been subject to a di...
